Literature DB >> 15953089

In vitro cytokine profile in childhood alopecia areata and the immunomodulatory effects of AS-101.

M Shohat1, D Mimouni, D Ben-Amitai, B Sredni, D Sredni, B Shohat, M David.   

Abstract

The aim of the present study was to determine the effect of AS-101, a known immunomodulator, on the pattern of cytokine production in children with patchy alopecia areata (PAA). Ten previously untreated children with PAA were compared to 10 healthy age- and sex-matched controls. Peripheral blood mononuclear cells (PBMC) were isolated from all participants. Unstimulated and phytohaemagglutinin (PHA)-stimulated PBMC were tested with and without the addition of AS-101. The production of interferon gamma (IFNgamma), soluble interleukin (IL)-2 receptor (IL-2R), IL-10, IL-5 and IL-6 was determined. The levels of soluble IL-2R, IL-5 and IL-6 were significantly higher in the PAA patients than the controls. AS-101 inhibited the production of IL-10, IFNgamma, IL-2R and IL-5 in both PAA patients and controls, but there was a greater inhibitory effect in children with PAA.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15953089     DOI: 10.1111/j.1365-2230.2005.01817.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  5 in total

1.  Impaired synthesis of erythropoietin, glutamine synthetase and metallothionein in the skin of NOD/SCID/gamma(c)(null) and Foxn1 nu/nu mice with misbalanced production of MHC class II complex.

Authors:  L Danielyan; S Verleysdonk; M Buadze; C H Gleiter; G H Buniatian
Journal:  Neurochem Res       Date:  2009-10-14       Impact factor: 3.996

2.  Maternal IL-6 can cause T-cell-mediated juvenile alopecia by non-scarring follicular dystrophy in mice.

Authors:  Stephen E P Smith; Rachel L G Maus; Tessa R Davis; John P Sundberg; Diana Gil; Adam G Schrum
Journal:  Exp Dermatol       Date:  2016-02-10       Impact factor: 3.960

3.  Serum concentrations of selected proinflammatory cytokines in children with alopecia areata.

Authors:  Katarzyna Tabara; Magdalena Kozłowska; Anna Jędrowiak; Wojciech Bienias; Andrzej Kaszuba
Journal:  Postepy Dermatol Alergol       Date:  2019-02-22       Impact factor: 1.837

Review 4.  Application of Topical Immunotherapy in the Treatment of Alopecia Areata: A Review and Update.

Authors:  Thipprapai Mahasaksiri; Chaninan Kositkuljorn; Tanaporn Anuntrangsee; Poonkiat Suchonwanit
Journal:  Drug Des Devel Ther       Date:  2021-03-23       Impact factor: 4.162

5.  Halo naevi, vitiligo and diffuse alopecia areata associated with tocilizumab therapy.

Authors:  Kavitha Nadesalingam; Mark Goodfield; Paul Emery
Journal:  Oxf Med Case Reports       Date:  2016-08-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.